Announcements
- Study of ovarian cancer CTCs using Parsortix
- New commercial agreement with large pharma
- New commercial agreement with AstraZeneca
- US and EU patents for innovative CellKeepâ„¢ slide
- Parsortix HER2 assay showcased at AACR 2024
- Parsortix at European breast cancer conference
- Potential utility in precision oncology
- Standard form for notification of major holdings
- Breakthrough clinical results
- Contract announcement with Eisai Inc.
More ▼
Key statistics
On Thursday, Angle PLC (DWV:DEU) closed at 0.22, 161.90% above the 52 week low of 0.084 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.226 |
---|---|
High | 0.236 |
Low | 0.204 |
Bid | 0.21 |
Offer | 0.248 |
Previous close | 0.216 |
Average volume | 0.00 |
---|---|
Shares outstanding | 260.58m |
Free float | 232.60m |
P/E (TTM) | -- |
Market cap | 50.81m GBP |
EPS (TTM) | -0.086 GBP |
Data delayed at least 15 minutes, as of May 23 2024.
More ▼